Literature DB >> 9371208

Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.

E M Baarends1, A M Schols, K R Westerterp, E F Wouters.   

Abstract

BACKGROUND: An elevated resting energy expenditure (REE) commonly occurs in patients with chronic obstructive pulmonary (COPD). The purpose of this study was to investigate the effect of an increased REE on total daily energy expenditure (TDE) in 20 patients with COPD (19 men) with mean (SD) forced expiratory volume in one second of 37 (14)% predicted.
METHODS: TDE was measured over a two week interval using doubly labelled water. Fat-free mass (FFM) was calculated from total body water assessed by deuterium dilution. REE was measured by indirect calorimetry using a ventilated hood system.
RESULTS: The patients (10 men) with a significantly higher REE than those with a normal REE (median difference 205 kcal/ 24 h, p < 0.05) had a comparable TDE (hypermetabolic at rest: median 2593; range 2127-3083 kcal/24 h, normometabolic at rest: median 2629; range 2032-3179 kcal/ 24 h). There was no difference in mean daily heart rate (HR) between the groups (hypermetabolic at rest: median 92 (range 82-98), normometabolic at rest: median 98 (range 75-116) beats/min) or in the variation in the heart rate during the day. By means of multiple regression analysis it was shown that REE did not correlate significantly with TDE when FEM was taken into account.
CONCLUSIONS: This study shows that there is no significant difference in free living TDE between clinically stable patients with COPD with a normal REE and those with an increased REE. The variation in TDE in patients with COPD appears to reflect differences in energy expenditure for activities, but not differences in REE.

Entities:  

Mesh:

Year:  1997        PMID: 9371208      PMCID: PMC1758652          DOI: 10.1136/thx.52.9.780

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

1.  Assessment of total energy expenditure in free-living patients with cystic fibrosis.

Authors:  V Spicher; M Roulet; Y Schutz
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

2.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.

Authors:  D O Wilson; R M Rogers; E C Wright; N R Anthonisen
Journal:  Am Rev Respir Dis       Date:  1989-06

3.  Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease.

Authors:  E M Baarends; A M Schols; D L Pannemans; K R Westerterp; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

4.  Nutritional state and exercise performance in patients with chronic obstructive lung disease.

Authors:  A M Schols; R Mostert; P B Soeters; L H Greve; E F Wouters
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

5.  Energy expenditure by doubly labeled water: validation in humans and proposed calculation.

Authors:  D A Schoeller; E Ravussin; Y Schutz; K J Acheson; P Baertschi; E Jéquier
Journal:  Am J Physiol       Date:  1986-05

6.  Energy balance in chronic obstructive pulmonary disease.

Authors:  A M Schols; P B Soeters; R Mostert; W H Saris; E F Wouters
Journal:  Am Rev Respir Dis       Date:  1991-06

7.  Effect of nutritional status on exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  K Gray-Donald; L Gibbons; S H Shapiro; J G Martin
Journal:  Am Rev Respir Dis       Date:  1989-12

8.  Energy expenditure in patients with chronic obstructive pulmonary disease.

Authors:  S Goldstein; J Askanazi; C Weissman; B Thomashow; J M Kinney
Journal:  Chest       Date:  1987-02       Impact factor: 9.410

9.  Resting energy expenditure in patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; E W Fredrix; P B Soeters; K R Westerterp; E F Wouters
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

10.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; W A Buurman; A J Staal van den Brekel; M A Dentener; E F Wouters
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

View more
  14 in total

1.  Decreased mechanical efficiency in clinically stable patients with COPD.

Authors:  E M Baarends; A M Schols; M A Akkermans; E F Wouters
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

Review 2.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 3.  Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update.

Authors:  Peter F Collins; Ian A Yang; Yuan-Chin Chang; Annalicia Vaughan
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  Body mass index and disease burden in elderly men and women: the Tromsø Study.

Authors:  Jan-Magnus Kvamme; Tom Wilsgaard; Jon Florholmen; Bjarne K Jacobsen
Journal:  Eur J Epidemiol       Date:  2010-01-20       Impact factor: 8.082

Review 5.  Energy expenditure and aging.

Authors:  Todd M Manini
Journal:  Ageing Res Rev       Date:  2009-08-19       Impact factor: 10.895

Review 6.  Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?

Authors:  Jean K Berry; Charles Baum
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

8.  Physical activity and physical activity induced energy expenditure in humans: measurement, determinants, and effects.

Authors:  Klaas R Westerterp
Journal:  Front Physiol       Date:  2013-04-26       Impact factor: 4.566

9.  Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry.

Authors:  Hans Van Remoortel; Yogini Raste; Zafeiris Louvaris; Santiago Giavedoni; Chris Burtin; Daniel Langer; Frederick Wilson; Roberto Rabinovich; Ioannis Vogiatzis; Nicholas S Hopkinson; Thierry Troosters
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 10.  Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  Ho Cheol Kim; Mahroo Mofarrahi; Sabah N A Hussain
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.